Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients: a MALDI study.

Lapolla A, Seraglia R, Molin L, Williams K, Cosma C, Reitano R, Sechi A, Ragazzi E, Traldi P.

J Mass Spectrom. 2009 Mar;44(3):419-25. doi: 10.1002/jms.1520.

PMID:
19165811
2.

A further investigation on a MALDI-based method for evaluation of markers of renal damage.

Lapolla A, Molin L, Sechi A, Cosma C, Ragazzi E, Seraglia R, Traldi P.

J Mass Spectrom. 2009 Dec;44(12):1754-60. doi: 10.1002/jms.1685.

PMID:
19852035
3.

On the search for glycated lipoprotein ApoA-I in the plasma of diabetic and nephropathic patients.

Lapolla A, Brioschi M, Banfi C, Tremoli E, Bonfante L, Cristoni S, Seraglia R, Traldi P.

J Mass Spectrom. 2008 Jan;43(1):74-81.

PMID:
17721906
4.
5.

Nonenzymatically glycated lipoprotein ApoA-I in plasma of diabetic and nephropathic patients.

Lapolla A, Brioschi M, Banfi C, Tremoli E, Cosma C, Bonfante L, Cristoni S, Seraglia R, Traldi P.

Ann N Y Acad Sci. 2008 Apr;1126:295-9. Epub 2007 Dec 13.

PMID:
18079481
6.

Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.

Jain S, Rajput A, Kumar Y, Uppuluri N, Arvind AS, Tatu U.

J Assoc Physicians India. 2005 Jun;53:513-20.

PMID:
16121805
7.

Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy.

Sharma K, Lee S, Han S, Lee S, Francos B, McCue P, Wassell R, Shaw MA, RamachandraRao SP.

Proteomics. 2005 Jul;5(10):2648-55.

PMID:
15984045
8.

Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2.

Riaz S, Skinner V, Srai SK.

J Pharm Biomed Anal. 2011 Mar 25;54(4):817-25. doi: 10.1016/j.jpba.2010.11.008. Epub 2010 Nov 13. Erratum in: J Pharm Biomed Anal. 2011 Aug 25;56(1):139.

PMID:
21130593
9.

Multivariate analysis of matrix-assisted laser desorption/ionization mass spectrometric data related to glycoxidation products of human globins in nephropathic patients.

Lapolla A, Ragazzi E, Andretta B, Fedele D, Tubaro M, Seraglia R, Molin L, Traldi P.

J Am Soc Mass Spectrom. 2007 Jun;18(6):1018-23. Epub 2007 Feb 22.

10.

Sieve-based device for MALDI sample preparation. III. Its power for quantitative measurements.

Molin L, Cristoni S, Seraglia R, Traldi P.

J Mass Spectrom. 2011 Feb;46(2):230-6. doi: 10.1002/jms.1885. Epub 2011 Jan 24.

PMID:
21259401
11.

Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.

Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X, Cui Y.

Diabetes Metab Res Rev. 2009 Mar;25(3):232-41. doi: 10.1002/dmrr.940.

PMID:
19177462
12.

Multivariate analysis approach to the plasma protein profile of patients with advanced colorectal cancer.

Ragazzi E, Pucciarelli S, Seraglia R, Molin L, Agostini M, Lise M, Traldi P, Nitti D.

J Mass Spectrom. 2006 Dec;41(12):1546-53.

PMID:
17117375
13.

Urinary peptides as a diagnostic tool for renal failure detected by matrix-assisted laser desorption/ionisation mass spectrometry: an evaluation of their clinical significance.

Lapolla A, Molin L, Seraglia R, Sechi A, Cosma C, Bonfante L, Chilelli NC, Ragazzi E, Traldi P.

Eur J Mass Spectrom (Chichester). 2011;17(3):245-53. doi: 10.1255/ejms.1124.

PMID:
21828415
14.

An investigation on the nature of the peptide at m/z 904, overexpressed in plasma of patients with colorectal cancer and familial adenomatous polyposis.

Seraglia R, Molin L, Tonidandel L, Pucciarelli S, Agostini M, Urso ED, Bedin C, Quaia M, Nitti D, Traldi P.

J Mass Spectrom. 2007 Dec;42(12):1606-12.

PMID:
18085540
15.

Proteomics and diabetic nephropathy.

Merchant ML, Klein JB.

Semin Nephrol. 2007 Nov;27(6):627-36. Review.

PMID:
18061845
16.

Proteomic identification of urinary biomarkers of diabetic nephropathy.

Rao PV, Lu X, Standley M, Pattee P, Neelima G, Girisesh G, Dakshinamurthy KV, Roberts CT Jr, Nagalla SR.

Diabetes Care. 2007 Mar;30(3):629-37. Erratum in: Diabetes Care. 2007 May;30(5):1330.

PMID:
17327332
17.

Proteomic analysis for the assessment of diabetic renal damage in humans.

Mischak H, Kaiser T, Walden M, Hillmann M, Wittke S, Herrmann A, Knueppel S, Haller H, Fliser D.

Clin Sci (Lond). 2004 Nov;107(5):485-95.

PMID:
15281910
18.

Comparative serum proteome expression of osteonecrosis of the femoral head in adults.

Wu RW, Wang FS, Ko JY, Wang CJ, Wu SL.

Bone. 2008 Sep;43(3):561-6. doi: 10.1016/j.bone.2008.04.019. Epub 2008 May 7.

PMID:
18572010
19.

Evaluation of IgG glycation levels by matrix-assisted laser desorption/ionization mass spectrometry.

Lapolla A, Fedele D, Aronica R, Garbeglio M, D'Alpaos M, Seraglia R, Traldi P.

Rapid Commun Mass Spectrom. 1997;11(12):1342-6.

PMID:
9276978
20.

A matrix-assisted laser desorption/ionization mass spectrometry study of the non-enzymatic glycation products of human globins in diabetes.

Lapolla A, Tubaro M, Fedele D, Reitano R, Aricò NC, Ragazzi E, Seraglia R, Vogliardi S, Traldi P.

Rapid Commun Mass Spectrom. 2005;19(2):162-8.

PMID:
15593243

Supplemental Content

Support Center